Primary Ciliary Dyskinesia Center
The Primary Ciliary Dyskinesia (PCD) Center specializes in diagnosing and treating adults with this rare genetic condition. The Center provides comprehensive multidisciplinary care for this serious condition that affects many organ systems. The PCD Center is committed to inclusivity, aims to address disparities in diagnosis and treatment, and provides support to individuals and families affected.
About PCD
PCD is caused by mutations in genes that control the structure and function of cilia, tiny hair-like structures in the airways that help clear inhaled particles and bacteria. When cilia don’t work correctly, individuals are prone to infections in the ears, sinuses, and lungs, which can lead to bronchiectasis – a serious lung condition.
In addition to chronic lung, ear, and sinus infections, PCD is characterized by other health problems, such as newborn respiratory distress, malpositioned internal organs, and fertility issues. PCD affects individuals from all racial and ethnic groups.
Diagnosis and Treatment
The PCD center is equipped with state-of-the-art technology, including access to a nasal nitric oxide machine, which aids in the diagnosis of PCD. Additionally, advanced genetic testing is available to provide accurate diagnoses and targeted treatment plans. We offer access to clinical trials of promising new medication in development.
Our dedicated team will create a personalized treatment plan to manage PCD symptoms. The PCD Center is the only center in the region that provides a true multidisciplinary clinic
Treatment plans may include:
- Personalized plan for airway clearance (maneuvers, medications, and devices to help clear mucus from the lungs).
- Medications to reduce inflammation and infection.
- Consultations with other specialists, including genetics, otolaryngology, infectious diseases, cardiology, and others as needed.
In Partnership With Connecticut Children’s
Connecticut Children's and UConn Health have partnered to provide coordinated, comprehensive care for PCD patients of all ages. The joint venture is poised to lead the nation in PCD diagnosis, education, and treatment. The PCD Center at Connecticut Children’s and UConn Health is one of only two centers of its kind in New England.
Research Focused
Both the pediatric and adult center sites are engaged in high-level pulmonary research, and all diagnosed patients are enrolled in the U.S. Bronchiectasis Research Registry (BRR) and the national PCD Registry that tracks PCD nationally to advance scientific knowledge and research.
Meet Our Team
Mark L. Metersky, M.D., FCCP, FACP
Farmington
Accepting New Patients
Make an Appointment
Call 1-84-GET-UCONN